Innovation Pharmaceuticals Inc (IPIX)

[williamssc]

Release reported departure was not a result of a disagreement. They will be interviewing for a new science officer in January so I will say his departure is not the result of a buyout as some speculate. Perhaps they're looking for someone who specializes more in the gastrointestinal area going forward.

On December 19, 2019, Arthur P. Bertolino resigned as President and Chief Medical Officer and as a member of the Board of Directors of Innovation Pharmaceuticals Inc. (the “Company”), effective immediately. Dr. Bertolino’s resignation was not a result of any disagreement with the Company.